Vitamin D and Pancreatic Cancer
Author Information
Author(s): KW Colston, SY James, EA Ofori-Kuragul, L Binderup, AG Grant
Primary Institution: St George's Hospital Medical School
Hypothesis
Can the vitamin D analogue EB 1089 inhibit the growth of pancreatic carcinoma cells both in vitro and in vivo?
Conclusion
The vitamin D analogue EB 1089 significantly inhibits the growth of pancreatic carcinoma cells without causing hypercalcaemia.
Supporting Evidence
- EB 1089 inhibited the growth of pancreatic carcinoma cells in vitro.
- EB 1089 was administered to mice and significantly inhibited tumor growth.
- Treatment did not result in hypercalcaemia in the treated animals.
Takeaway
This study found that a special form of vitamin D can help stop the growth of pancreatic cancer cells in lab tests and in mice.
Methodology
The study used human pancreatic carcinoma cell lines and xenografts in immunodeficient mice to assess the effects of EB 1089.
Limitations
The study is preliminary and the mechanisms of action of EB 1089 are not fully understood.
Participant Demographics
Female nude mice, 6-8 weeks of age.
Statistical Information
P-Value
0.007
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website